Better Therapeutics, Inc.

BTTX

BTTXBetter Therapeutics, Inc. US flag

Other OTC

0.00

USD

- -

5,452.00Market Cap

Income Statement (USD)

API ChatGPT

	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Sales/Revenue/Turnover	- -	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -	- -
- Cost of Revenue	1	1	- -	- -
+ Cost of Goods & Services	1	1	- -	- -
Gross Profit	-1	-1	- -	- -
+ Other Operating Income	- -	-1	- -	- -
- Operating Expenses	5	6	31	38
+ Selling, General & Admin	3	3	11	22
+ Research & Development	2	4	19	16
+ Other Operating Expense	- -	- -	- -	- -
Operating Income (Loss)	-6	-6	-31	-38
- Non-Operating (Income) Loss	- -	- -	10	1
+ Interest Expense, Net	- -	- -	- -	1
+ Interest Expense	- -	- -	- -	1
- Interest Income	- -	- -	- -	- -
+ Other Non-Op (Income) Loss	- -	- -	10	- -
Pretax Income	-6	-6	-40	-40
- Income Tax Expense (Benefit)	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -
Income (Loss) from Cont Ops	-6	-6	-40	-40
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -
Income (Loss) Incl. MI	-6	-6	-40	-40
- Minority Interest	- -	- -	- -	- -
Net Income, GAAP	-6	-6	-40	-40
- Preferred Dividends	1	2	- -	- -
- Other Adjustments	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-7	-8	-40	-40
EBIT	-6	-6	-31	-38
EBITDA	-6	-6	-29	-36
EBITDA Margin (%)	-31,672.22	-78,100	- -	- -
EBITA	-6	-6	-31	-38
Gross Margin (%)	-4,888.89	-8,425	- -	- -
Operating Margin (%)	-32,072.22	-79,037.5	- -	- -
Profit Margin (%)	-32,133.33	-79,837.5	- -	- -
Sales per Employee	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -
Depreciation Expense	- -	- -	2	3
Basic Weighted Avg Shares	24	24	13	24
Basic EPS, GAAP	-0.3	-0.33	-3.11	-1.69
Basic EPS from Cont Ops	-0.25	-0.27	-3.11	-1.69
Diluted Weighted Avg Shares	24	24	13	24
Diluted EPS, GAAP	-0.3	-0.33	-3.11	-1.69
Diluted EPS from Cont Ops	-0.25	-0.27	-3.11	-1.69

Balance Sheet (USD)

API ChatGPT

	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Total Current Assets	1	- -	45	18
+ Cash, Cash Equivalents & STI	1	- -	41	16
+ Cash & Cash Equivalents	1	- -	41	16
+ ST Investments	- -	- -	- -	- -
+ Accounts & Notes Receiv	- -	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -
+ Other ST Assets	- -	- -	5	3
+ Misc ST Assets	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -
Total Noncurrent Assets	4	6	6	4
+ Property, Plant & Equip, Net	- -	- -	- -	- -
+ Property, Plant & Equip	- -	- -	- -	- -
- Accumulated Depreciation	- -	- -	- -	- -
+ LT Investments & Receivables	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -
+ Other LT Assets	4	6	6	4
+ Total Intangible Assets	3	6	5	4
+ Goodwill	- -	- -	- -	- -
+ Other Intangible Assets	3	6	5	4
+ LT Deferred Tax Assets	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	1	- -
Total Assets	5	6	51	23
+ Payables & Accruals	- -	1	5	9
+ Accounts Payable	- -	1	2	3
+ Accrued Taxes	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -
+ Other Payables & Accruals	- -	- -	3	6
+ ST Debt	- -	- -	- -	5
+ ST Borrowings	- -	- -	- -	5
+ ST Finance Leases	- -	- -	- -	- -
+ Other ST Liabilities	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Misc ST Liabilities	- -	- -	- -	- -
Total Current Liabilities	- -	1	5	13
+ LT Debt	5	1	10	10
+ LT Borrowings	5	1	10	10
+ LT Finance Leases	- -	- -	- -	- -
+ Other LT Liabilities	- -	12	- -	- -
+ Accrued Liabilities	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Misc LT Liabilities	- -	12	- -	- -
Total Noncurrent Liabilities	5	13	10	10
Total Liabilities	5	13	14	24
+ Preferred Equity and Hybrid Capital	24	24	- -	- -
+ Share Capital & APIC	- -	25	108	111
+ Common Stock	- -	- -	- -	- -
+ Additional Paid in Capital	- -	25	108	111
- Treasury Stock	- -	- -	- -	- -
+ Retained Earnings	-25	-31	-72	-112
+ Other Equity	- -	- -	- -	- -
Equity Before Minority Interest	-1	-7	37	-1
+ Minority/Non Controlling Interest	- -	- -	- -	- -
Total Equity	-1	-7	37	-1
Total Liabilities & Equity	5	6	51	23
Shares Outstanding	24	24	24	24
Number of Employees	- -	- -	- -	- -
Capital Leases - Total	- -	- -	- -	- -
Net Debt	4	1	-31	-1
Net Debt to Equity	-701.32	-7.65	-84.59	95.66
Tangible Common Equity Ratio	-1,739.53	-4,389.06	68.97	-25.12
Current Ratio	2.03	0.76	9.56	1.37
Cash Conversion Cycle	- -	-227.19	- -	- -

Cash Flow Statement (USD)

API ChatGPT

	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022

+ Net Income	-6	-6	-40	-40
+ Depreciation & Amortization	- -	- -	2	3
+ Non-Cash Items	- -	- -	10	2
+ Stock-Based Compensation	- -	- -	1	2
+ Deferred Income Taxes	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -
+ Other Non-Cash Adj	- -	- -	10	- -
+ Chg in Non-Cash Work Cap	-1	- -	-2	6
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	-1	- -	-5	2
+ Inc (Dec) in Accts Payable	- -	- -	2	4
+ Inc (Dec) in Other	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Operating Activities	-6	-6	-31	-29
+ Change in Fixed & Intang	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -
+ Acq of Fixed & Intang	-3	-2	-1	- -
+ Acq of Fixed Prod Assets	- -	- -	- -	- -
+ Acq of Intangible Assets	-3	-2	-1	- -
+ Cash (Repurchase) of Equity	- -	- -	- -	- -
+ Increase in Capital Stock	- -	- -	- -	- -
+ Decrease in Capital Stock	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	- -	- -
+ Dec in LT Investment	- -	- -	- -	- -
+ Inc in LT Investment	- -	- -	- -	- -
+ Net Cash From Acq & Div	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	-1
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Investing Activities	-3	-2	-1	-1
+ Dividends Paid	- -	- -	- -	- -
+ Net Cash From Debt	5	7	29	5
+ Cash From Debt	5	7	29	5
+ Repayments of Debt	- -	- -	- -	- -
+ Other Financing Activities	4	- -	44	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Financing Activities	9	7	72	5
Effect of Foreign Exchange Rates	- -	- -	- -	- -
Net Changes in Cash	- -	-1	40	-25
EBITDA	-6	-6	-29	-36
EBITDA Margin (%)	-31,672.22	-78,100	- -	- -
Free Cash Flow	-9	-8	-32	-29
Net Cash Paid for Acquisitions	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -
Free Cash Flow to Equity	- -	- -	-26	-24
Free Cash Flow per Basic Share	-0.38	-0.34	-2.46	-1.23
Price/Free Cash Flow	- -	- -	-2.03	-0.91
Cash Flow to Net Income	1.07	0.9	0.76	0.73
Capital Expenditures	-3	-2	-1	- -